{"entity":{"type":"insider","cik":"0001837647","url":"/insider/0001837647","json_url":"/insider/0001837647.json","name":"Martin Michael Robert","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":12,"first":"2021-06-23","last":"2022-11-09","span_basis":"filed_date"},"name_variants":[{"name":"Martin Michael Robert","source":"filing","n_filings":12,"first_seen":"2021-06-23","last_seen":"2022-11-09"}],"transactions":[{"id":6581169,"accession":"0001628280-22-029215","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-029215","line_url":"/filing/0001628280-22-029215#line-1","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001837647","owner_name":"Martin Michael Robert","owner_display_name":"Martin Michael Robert","owner_url":"/insider/0001837647","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":5.16,"price_display":"5.16","price_state":"stated","total_value":154800.0,"total_display":"154,800.00","total_whole":"154,800","shares_owned_after":89512.0,"shares_owned_after_display":"89,512","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-07","filed_date":"2022-11-09","scope":"insider"},{"id":6377578,"accession":"0001628280-22-005130","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-22-005130","line_url":"/filing/0001628280-22-005130#line-2","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001837647","owner_name":"Martin Michael Robert","owner_display_name":"Martin Michael Robert","owner_url":"/insider/0001837647","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4849.0,"shares_display":"4,849","price_per_share":12.01,"price_display":"12.01","price_state":"stated","total_value":58236.49,"total_display":"58,236.49","total_whole":"58,236","shares_owned_after":59512.0,"shares_owned_after_display":"59,512","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-02","filed_date":"2022-03-04","scope":"insider"},{"id":5079451,"accession":"0001628280-21-023169","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001628280-21-023169","line_url":"/filing/0001628280-21-023169","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001837647","owner_name":"Martin Michael Robert","owner_display_name":"Martin Michael Robert","owner_url":"/insider/0001837647","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":29.007,"price_display":"29.01","price_state":"stated","total_value":1160280.0,"total_display":"1,160,280.00","total_whole":"1,160,280","shares_owned_after":66861.0,"shares_owned_after_display":"66,861","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-11","filed_date":"2021-11-12","scope":"insider","n_lines":2},{"id":5079436,"accession":"0001628280-21-023169","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-21-023169","line_url":"/filing/0001628280-21-023169","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001837647","owner_name":"Martin Michael Robert","owner_display_name":"Martin Michael Robert","owner_url":"/insider/0001837647","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":31.141666666666666,"price_display":"31.14","price_state":"stated","total_value":1868500.0,"total_display":"1,868,500.00","total_whole":"1,868,500","shares_owned_after":76861.0,"shares_owned_after_display":"76,861","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-10","filed_date":"2021-11-12","scope":"insider","n_lines":2},{"id":5079425,"accession":"0001628280-21-023169","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-21-023169","line_url":"/filing/0001628280-21-023169#line-1","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001837647","owner_name":"Martin Michael Robert","owner_display_name":"Martin Michael Robert","owner_url":"/insider/0001837647","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":30.17,"price_display":"30.17","price_state":"stated","total_value":1508500.0,"total_display":"1,508,500.00","total_whole":"1,508,500","shares_owned_after":126861.0,"shares_owned_after_display":"126,861","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-09","filed_date":"2021-11-12","scope":"insider"},{"id":5267249,"accession":"0001628280-21-021477","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-21-021477","line_url":"/filing/0001628280-21-021477#line-2","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001837647","owner_name":"Martin Michael Robert","owner_display_name":"Martin Michael Robert","owner_url":"/insider/0001837647","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45000.0,"shares_display":"45,000","price_per_share":31.64,"price_display":"31.64","price_state":"stated","total_value":1423800.0,"total_display":"1,423,800.00","total_whole":"1,423,800","shares_owned_after":176861.0,"shares_owned_after_display":"176,861","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-01","filed_date":"2021-11-03","scope":"insider"},{"id":4110448,"accession":"0001628280-21-019048","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001628280-21-019048","line_url":"/filing/0001628280-21-019048#line-4","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001837647","owner_name":"Martin Michael Robert","owner_display_name":"Martin Michael Robert","owner_url":"/insider/0001837647","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":87500.0,"shares_display":"87,500","price_per_share":24.02,"price_display":"24.02","price_state":"stated","total_value":2101750.0,"total_display":"2,101,750.00","total_whole":"2,101,750","shares_owned_after":176861.0,"shares_owned_after_display":"176,861","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-21","filed_date":"2021-09-22","scope":"insider"},{"id":4110442,"accession":"0001628280-21-019048","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-21-019048","line_url":"/filing/0001628280-21-019048","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001837647","owner_name":"Martin Michael Robert","owner_display_name":"Martin Michael Robert","owner_url":"/insider/0001837647","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28500.0,"shares_display":"28,500","price_per_share":21.648245614035087,"price_display":"21.65","price_state":"stated","total_value":616975.0,"total_display":"616,975.00","total_whole":"616,975","shares_owned_after":176861.0,"shares_owned_after_display":"176,861","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-20","filed_date":"2021-09-22","scope":"insider","n_lines":2},{"id":5419329,"accession":"0001628280-21-018782","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-21-018782","line_url":"/filing/0001628280-21-018782","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001837647","owner_name":"Martin Michael Robert","owner_display_name":"Martin Michael Robert","owner_url":"/insider/0001837647","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44000.0,"shares_display":"44,000","price_per_share":21.777727272727272,"price_display":"21.78","price_state":"stated","total_value":958220.0,"total_display":"958,220.00","total_whole":"958,220","shares_owned_after":176861.0,"shares_owned_after_display":"176,861","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-14","filed_date":"2021-09-16","scope":"insider","n_lines":2},{"id":4333920,"accession":"0001628280-21-018603","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001628280-21-018603","line_url":"/filing/0001628280-21-018603#line-5","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001837647","owner_name":"Martin Michael Robert","owner_display_name":"Martin Michael Robert","owner_url":"/insider/0001837647","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":90000.0,"shares_display":"90,000","price_per_share":21.1913,"price_display":"21.19","price_state":"stated","total_value":1907217.0,"total_display":"1,907,217.00","total_whole":"1,907,217","shares_owned_after":176861.0,"shares_owned_after_display":"176,861","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-14","filed_date":"2021-09-14","scope":"insider"},{"id":4333902,"accession":"0001628280-21-018603","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-21-018603","line_url":"/filing/0001628280-21-018603#line-1","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001837647","owner_name":"Martin Michael Robert","owner_display_name":"Martin Michael Robert","owner_url":"/insider/0001837647","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":19.8,"price_display":"19.80","price_state":"stated","total_value":495000.0,"total_display":"495,000.00","total_whole":"495,000","shares_owned_after":176861.0,"shares_owned_after_display":"176,861","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-10","filed_date":"2021-09-14","scope":"insider"},{"id":5473142,"accession":"0001628280-21-018219","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-21-018219","line_url":"/filing/0001628280-21-018219#line-1","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001837647","owner_name":"Martin Michael Robert","owner_display_name":"Martin Michael Robert","owner_url":"/insider/0001837647","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":18.1,"price_display":"18.10","price_state":"stated","total_value":135750.0,"total_display":"135,750.00","total_whole":"135,750","shares_owned_after":176861.0,"shares_owned_after_display":"176,861","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-07","filed_date":"2021-09-08","scope":"insider"},{"id":4152148,"accession":"0001628280-21-017720","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-21-017720","line_url":"/filing/0001628280-21-017720#line-1","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001837647","owner_name":"Martin Michael Robert","owner_display_name":"Martin Michael Robert","owner_url":"/insider/0001837647","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22500.0,"shares_display":"22,500","price_per_share":17.81,"price_display":"17.81","price_state":"stated","total_value":400725.0,"total_display":"400,725.00","total_whole":"400,725","shares_owned_after":184361.0,"shares_owned_after_display":"184,361","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-26","filed_date":"2021-08-27","scope":"insider"},{"id":4490099,"accession":"0001628280-21-016403","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-21-016403","line_url":"/filing/0001628280-21-016403#line-1","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001837647","owner_name":"Martin Michael Robert","owner_display_name":"Martin Michael Robert","owner_url":"/insider/0001837647","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":16.01,"price_display":"16.01","price_state":"stated","total_value":80050.0,"total_display":"80,050.00","total_whole":"80,050","shares_owned_after":206861.0,"shares_owned_after_display":"206,861","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-09","filed_date":"2021-08-10","scope":"insider"},{"id":4739117,"accession":"0001628280-21-014882","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-21-014882","line_url":"/filing/0001628280-21-014882#line-1","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001837647","owner_name":"Martin Michael Robert","owner_display_name":"Martin Michael Robert","owner_url":"/insider/0001837647","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":13.86,"price_display":"13.86","price_state":"stated","total_value":69300.0,"total_display":"69,300.00","total_whole":"69,300","shares_owned_after":211861.0,"shares_owned_after_display":"211,861","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-28","filed_date":"2021-07-29","scope":"insider"},{"id":5473025,"accession":"0001628280-21-012730","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-21-012730","line_url":"/filing/0001628280-21-012730#line-1","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001837647","owner_name":"Martin Michael Robert","owner_display_name":"Martin Michael Robert","owner_url":"/insider/0001837647","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":13.76,"price_display":"13.76","price_state":"stated","total_value":68800.0,"total_display":"68,800.00","total_whole":"68,800","shares_owned_after":216861.0,"shares_owned_after_display":"216,861","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-22","filed_date":"2021-06-23","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":20,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":19,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":20},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001600620","name":"Aurinia Pharmaceuticals Inc.","url":"/issuer/0001600620","role":"Officer (Chief Business Officer)","n_filings":12,"first_seen":"2021-06-23","last_seen":"2022-11-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001837647","retrieved_at":"2026-08-24T06:32:14+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}